Search Results
DDx Strength: Weak
infigratinib, Rash or multiple lesions

Edit Findings

Exanthematous drug eruption

Exanthematous drug eruptionExanthematous drug eruption

Onycholysis

OnycholysisOnycholysis

Xerosis

XerosisXerosis

Acral erythema

Acral erythemaAcral erythema

Drug-induced hepatotoxicity

Drug-induced hepatotoxicity

Calcinosis cutis

Calcinosis cutisCalcinosis cutis

Drug-induced abdominal pain

Drug-induced abdominal pain

Drug-induced diarrhea

Drug-induced diarrhea

Drug-induced dyspepsia

Drug-induced dyspepsia

Drug-induced nausea or vomiting

Drug-induced nausea or vomiting

Keratoconjunctivitis sicca syndrome

Keratoconjunctivitis sicca syndrome

Chemotherapy-induced mucositis

Chemotherapy-induced mucositisChemotherapy-induced mucositis

Drug-induced alopecia

Drug-induced alopeciaDrug-induced alopecia

Drug-induced anorexia

Drug-induced anorexia

Drug-induced arthralgia

Drug-induced arthralgia

Drug-induced constipation

Drug-induced constipation

Drug-induced dysgeusia

Drug-induced dysgeusia

Drug-induced fatigue

Drug-induced fatigue

Drug-induced headache

Drug-induced headache

Drug-induced nail pigment

Drug-induced nail pigmentDrug-induced nail pigment

Drug-induced paronychia

Drug-induced paronychiaDrug-induced paronychia

Drug-induced weight loss

Drug-induced weight loss

Hyperbilirubinemia

Hyperbilirubinemia

Hyponatremia

Hyponatremia

Ocular drug reaction

Ocular drug reaction

Onychomadesis

OnychomadesisOnychomadesis

Retinal detachment

Retinal detachmentRetinal detachment

Drug-induced fever

Drug-induced fever

Drug-induced hyperlipasemia

Drug-induced hyperlipasemia

Hypercalcemia

Hypercalcemia

Hyperkalemia

Hyperkalemia

Drug-induced anemia

Drug-induced anemia